In the recent federal budget, the Australian Government revealed it would provide indemnity against liability for both the AstraZeneca Oxford  and the University of Queensland COVID-19 vaccine candidates. Should either vaccine be approved, and if rare side-effects occur, the government will be responsible for providing compensation. Vaccine compensation schemes currently exist in many countries however, at present Australia is not one of them.

The following article, published in The Conversation, outlines what is known about the proposed indemnity deal and what it means for Australians.

要阅读全文,请点击以下链接:

The Conversation: Who pays compensation if a COVID-19 vaccine has rare side-effects? Here’s the little we know about Australia’s new deal

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个